Cargando…
Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
BACKGROUND: Idiopathic intracranial hypertension (IIH) is a condition predominantly affecting obese women of reproductive age. Recent evidence suggests that IIH is a disease of metabolic dysregulation, androgen excess, and an increased risk of cardiovascular morbidity. Here we evaluate systemic and...
Autores principales: | Westgate, Connar S.J., Botfield, Hannah F., Alimajstorovic, Zerin, Yiangou, Andreas, Walsh, Mark, Smith, Gabrielle, Singhal, Rishi, Mitchell, James L., Grech, Olivia, Markey, Keira A., Hebenstreit, Daniel, Tennant, Daniel A., Tomlinson, Jeremy W., Mollan, Susan P., Ludwig, Christian, Akerman, Ildem, Lavery, Gareth G., Sinclair, Alexandra J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262372/ https://www.ncbi.nlm.nih.gov/pubmed/33848268 http://dx.doi.org/10.1172/jci.insight.145346 |
Ejemplares similares
-
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022) -
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
por: Markey, Keira, et al.
Publicado: (2020) -
11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
por: Hardy, Rowan S, et al.
Publicado: (2020) -
Emerging themes in idiopathic intracranial hypertension
por: Grech, Olivia, et al.
Publicado: (2020) -
Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)